US Drug Recall Register

Is Histamine recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Histamine (109 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Histamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Wal-Fex Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0363-0903-62 D-0353-2022
Class II · Moderate risk Terminated

Wal-Fex Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0363-0600-13 D-0352-2022
Class II · Moderate risk Terminated

up&up allergy relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 11673-571-22 D-0351-2022
Class II · Moderate risk Terminated

TopCare Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 36800-319-13 D-0350-2022
Class II · Moderate risk Terminated

TopCare Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 36800-954-53 D-0349-2022
Class II · Moderate risk Terminated

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 11822-0571-2 D-0348-2022
Class II · Moderate risk Terminated

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 11822-0425-0 D-0347-2022
Class II · Moderate risk Terminated

Perrigo Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 45802-425-78 D-0346-2022
Class II · Moderate risk Terminated

Perrigo Fexofenadine Hydrochloride tablets

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 45802-571-78 D-0345-2022
Class II · Moderate risk Terminated

allergyrelief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 56062-571-22 D-0344-2022
Class II · Moderate risk Terminated

Meijer allergy relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 41250-060-22 D-0343-2022
Class II · Moderate risk Terminated

Major

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0904-6979-60 D-0342-2022
Class II · Moderate risk Terminated

Kroger Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 30142-555-53 D-0341-2022
Class II · Moderate risk Terminated

H.E.B Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 37808-571-22 D-0340-2022
Class II · Moderate risk Terminated

H.E.B Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 37808-425-53 D-0339-2022
Class II · Moderate risk Terminated

Health Mart

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 62011-0233-1 D-0338-2022
Class II · Moderate risk Terminated

Health Mart

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 62011-0413-1 D-0337-2022
Class II · Moderate risk Terminated

DG/health Aller.Ease

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC D-0336-2022
Class II · Moderate risk Terminated

CVS Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 59779-425-53 D-0335-2022
Class II · Moderate risk Terminated

CAREONE Allergy Relief

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 41520-229-39 D-0334-2022
Class II · Moderate risk Terminated

berkley jensen

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC D-0333-2022
Class II · Moderate risk Terminated

basic+care

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0113-7425-78 D-0332-2022
Class II · Moderate risk Terminated

basic+care

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC NDC 0113-7571-47 D-0331-2022
Class II · Moderate risk Terminated

amazon

Reason Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Perrigo Company PLC D-0330-2022
Class II · Moderate risk Terminated

Children's Loratadine Oral Solution USP

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 51672-2131-8 D-0572-2021